Shortness of breath in autoimmune myasthenia gravis: causes and testing
Official title: Evaluating Dyspnea in Autoimmune Myasthenia Gravis "Why am I Short of Breath?"
Run by Institut de Myologie, France · NCT06866652 · Data updated 2026-11-12
We will see if patient-reported symptoms and specific clinical tests can identify the causes of shortness of breath in adults with autoimmune myasthenia gravis.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Institut de Myologie, France Academic / other |
| Locations | 1 site (Paris) |
| Status | Recruiting |
| Started | April 8, 2026 |
| Main results expected | June 2028 |
| Study ends | June 2028 |
| Registry record updated | May 8, 2026 |
| Trial ID | NCT06866652 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18) with a confirmed diagnosis of autoimmune myasthenia gravis who report daily-life shortness of breath (eligible MG-ADL respiration item score) and can provide informed consent are appropriate candidates.
✕Probably not a fit
Patients without current dyspnea, those with other known respiratory disorders, recent respiratory infection, current MG crisis, pregnancy, or severe cognitive impairment/guardianship are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
MYaResp is a prospective observational, cross-sectional study that examines breathlessness in adults with autoimmune myasthenia gravis. Adults who report daily-life shortness of breath will complete questionnaires and undergo clinical and physiological testing to characterize the sensation, its severity, and its functional impact. The study will compare patient-reported dyspnea with disease severity measures and objective tests to identify contributing factors and the most informative diagnostic tests. Results are intended to inform targeted management strategies and monitoring to reduce respiratory deterioration and improve quality of life.
Why it matters
Potential benefit: If successful, this work could help clinicians pinpoint causes of breathlessness in MG and guide treatments to reduce discomfort and lower the risk of respiratory worsening.
How similar studies have gone: Some prior observational studies have described respiratory involvement in MG, but few have systematically linked patient-reported dyspnea with a broad set of clinical and physiological tests, so this approach is partly novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥18 * Confirmed diagnosis of autoimmune MG * Shortness of breath in daily life: score 1 or 2 on the respiration item on the MG- activities of daily living score * Signed consent form * Affiliated to or beneficiary of a social security scheme Exclusion Criteria: * Known Pregnancy * Known respiratory disorder (other than MG) * Recent (within past 4 weeks) respiratory infection * Current MG crisis or exacerbation (necessitating increase in MG medication \&/or hospital admission) * No dyspnea - score 0 or 3 on the respiration item on the MG- activities of daily living score * Severe cognitive impairment/guardianship
Where it's running
-
Institute of Myology
Paris, France Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pulmonary and cardiovascular rehabilitation program for chronic respiratory and heart conditions
This study tests a rehabilitation program that combines exercise for people with chronic lung and heart conditions to see if it helps them feel better and improve their daily activities.
-
Assessing diaphragm function in patients with respiratory diseases
This study is testing how well the diaphragm works in people with respiratory diseases to see if it affects their breathing difficulties and overall health.
-
Wintergreen oil inhalation for shortness of breath in pneumonia patients
Hospitals will test whether inhaling wintergreen essential oil helps relieve dyspnea in adults with pneumonia.
-
Difference in finger, earlobe, and forehead oxygen levels to predict outcomes in dyspnea
In adults with breathing trouble, this study tests whether differences in SpO2 readings from different body sites can predict who might have worse outcomes.
-
MG patient registry to track long-term experiences and treatment patterns
This registry collects information from adults with myasthenia gravis to see how symptoms and quality of life change over time and how treatments relate to those changes.
-
See if video telemedicine with a caller’s mobile camera improves care for adults with acute dyspnea
This study tests whether adding video calls from a caller’s mobile phone to the emergency dispatch process helps improve care for adults with acute shortness of breath.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.